PSAT1 was found to be upregulated in ovarian cancer, breast cancer, and non-small cell lung cancer, enhancing cell proliferation, metastasis and chemical resistance, all of which result in poor prognosis [15,16,22]. This evidence concerns the gene PSAT1 and breast carcinoma.